TrialAnnals of oncology : official journal of the European Society for Medical Oncology2019

Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up.

Y Fradet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.